Drug Patent Expirations for the week of August 12, 2012
| Tradename | Applicant | Generic Name | Patent Number | Patent Expiration | |||||
|---|---|---|---|---|---|---|---|---|---|
| EXELON | Novartis | rivastigmine tartrate | 4,948,807 | Aug 14, 2012 | |||||
| EXELON | Novartis | rivastigmine | 4,948,807 | Aug 14, 2012 | |||||
| VITRAVENE PRESERVATIVE FREE | Novartis | fomivirsen sodium | 5,442,049 | Aug 15, 2012 | |||||
| VITRAVENE PRESERVATIVE FREE | Novartis | fomivirsen sodium | 5,595,978 | Aug 15, 2012 | |||||
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.
| |||||||||
No comments:
Post a Comment